Hospital Based Dermatopathology an Illustrated Diagnostic Guide
Adverse Cutaneous Reactions to Chemotherapeutic Agents
Publication
, Chapter
Hoang, MP; Kroshinsky, D
January 1, 2020
As major advancements in cancer treatment are being made, adverse effects including cutaneous ones are increased in parallel. The cutaneous adverse events result in declined quality of life as well as increased cost of health care. Awareness of the spectrum of these adverse cutaneous reaction patterns is important since they can change the treatment strategy. In this chapter the common cutaneous adverse reactions associated with chemotherapy, tumor necrosis factor-α inhibitor, granulocyte-macrophage colony-stimulating factor, epidermal growth factor inhibitor, kinase inhibitors, immune checkpoint blockade, and other targeted therapies will be discussed.
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Hoang, M. P., & Kroshinsky, D. (2020). Adverse Cutaneous Reactions to Chemotherapeutic Agents. In Hospital Based Dermatopathology an Illustrated Diagnostic Guide (pp. 757–795). https://doi.org/10.1007/978-3-030-35820-4_16
Hoang, M. P., and D. Kroshinsky. “Adverse Cutaneous Reactions to Chemotherapeutic Agents.” In Hospital Based Dermatopathology an Illustrated Diagnostic Guide, 757–95, 2020. https://doi.org/10.1007/978-3-030-35820-4_16.
Hoang MP, Kroshinsky D. Adverse Cutaneous Reactions to Chemotherapeutic Agents. In: Hospital Based Dermatopathology an Illustrated Diagnostic Guide. 2020. p. 757–95.
Hoang, M. P., and D. Kroshinsky. “Adverse Cutaneous Reactions to Chemotherapeutic Agents.” Hospital Based Dermatopathology an Illustrated Diagnostic Guide, 2020, pp. 757–95. Scopus, doi:10.1007/978-3-030-35820-4_16.
Hoang MP, Kroshinsky D. Adverse Cutaneous Reactions to Chemotherapeutic Agents. Hospital Based Dermatopathology an Illustrated Diagnostic Guide. 2020. p. 757–795.